Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

BioMed Research International
Volume 2016, Article ID 1473578, 7 pages
http://dx.doi.org/10.1155/2016/1473578
Research Article

Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish

1New Drug Development Center, Osong Medical Innovation Foundation, Chungbuk 28160, Republic of Korea
2Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea
3Department of Biology, Chungnam National University, Daejeon 34134, Republic of Korea
4Department of Drug Discovery Platform Technology, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea
5Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea
6College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea

Received 15 April 2016; Revised 20 June 2016; Accepted 4 July 2016

Academic Editor: Minjun Chen

Copyright © 2016 Hyun-Sik Nam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ozer, M. Ratner, M. Shaw, W. Bailey, and S. Schomaker, “The current state of serum biomarkers of hepatotoxicity,” Toxicology, vol. 245, no. 3, pp. 194–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. V. J. Navarro and J. R. Senior, “Drug-related hepatotoxicity,” New England Journal of Medicine, vol. 354, no. 7, pp. 731–739, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ostapowicz, R. J. Fontana, F. V. Schioødt et al., “Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States,” Annals of Internal Medicine, vol. 137, no. 12, pp. 947–954, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Gómez-Lechón, L. Tolosa, I. Conde, and M. T. Donato, “Competency of different cell models to predict human hepatotoxic drugs,” Expert Opinion on Drug Metabolism and Toxicology, vol. 10, no. 11, pp. 1553–1568, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Dove, “Drug screening—beyond the bottleneck,” Nature Biotechnology, vol. 17, no. 9, pp. 859–863, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Dove, “Screening for content—the evolution of high throughput,” Nature Biotechnology, vol. 21, no. 8, pp. 859–864, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. Spitsbergen and M. L. Kent, “The state of the art of the zebrafish model for toxicology and toxicologic pathology research—advantages and current limitations,” Toxicologic Pathology, vol. 31, supplement 1, pp. 62–87, 2003. View at Google Scholar · View at Scopus
  8. H. Teraoka, W. Dong, and T. Hiraga, “Zebrafish as a novel experimental model for developmental toxicology,” Congenital Anomalies, vol. 43, no. 2, pp. 123–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Westerfield, The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio Rerio), University of Oregon Press, Eugene, Ore, USA, 4th edition, 2000.
  10. A. A. Shah, P. Leidinger, N. Blin, and E. Meese, “miRNA: small molecules as potential novel biomarkers in cancer,” Current Medicinal Chemistry, vol. 17, no. 36, pp. 4427–4432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, “Most mammalian mRNAs are conserved targets of microRNAs,” Genome Research, vol. 19, no. 1, pp. 92–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki, and T. Ochiya, “Secretory mechanisms and intercellular transfer of microRNAs in living cells,” The Journal of Biological Chemistry, vol. 285, no. 23, pp. 17442–17452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Vasudevan, Y. Tong, and J. A. Steitz, “Switching from repression to activation: microRNAs can up-regulate translation,” Science, vol. 318, no. 5858, pp. 1931–1934, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zhang, Y. Jia, R. Zheng et al., “Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases,” Clinical Chemistry, vol. 56, no. 12, pp. 1830–1838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Starckx, A. Batheja, G. R. Verheyen et al., “Evaluation of miR-122 and other biomarkers in distinct acute liver injury in rats,” Toxicologic Pathology, vol. 41, no. 5, pp. 795–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Ason, D. K. Darnell, B. Wittbrodt et al., “Differences in vertebrate microRNA expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 39, pp. 14385–14389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Lagos-Quintana, R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl, “Identification of tissue-specific microRNAs from mouse,” Current Biology, vol. 12, no. 9, pp. 735–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. E. North, I. R. Babu, L. M. Vedder et al., “PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 40, pp. 17315–17320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-M. Jeong, T.-E. Jin, J.-H. Choi et al., “Induction of clusterin expression by neuronal cell death in Zebrafish,” Journal of Genetics and Genomics, vol. 41, no. 11, pp. 583–589, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. I. W. Y. Mak, N. Evaniew, and M. Ghert, “Lost in translation: animal models and clinical trials in cancer treatment,” American Journal of Translational Research, vol. 6, no. 2, pp. 114–118, 2014. View at Google Scholar · View at Scopus
  22. D. Raldúa and B. Piña, “In vivo zebrafish assays for analyzing drug toxicity,” Expert Opinion on Drug Metabolism and Toxicology, vol. 10, no. 5, pp. 685–697, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Kaplowitz, “Drug-induced liver disorders: implications for drug development and regulation,” Drug Safety, vol. 24, no. 7, pp. 483–490, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. P. B. Watkins, P. J. Seligman, J. S. Pears, M. I. Avigan, and J. R. Senior, “Using controlled clinical trials to learn more about acute drug-induced liver injury,” Hepatology, vol. 48, no. 5, pp. 1680–1689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Suzuki, R. J. Andrade, E. Bjornsson et al., “Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in vigibase: unified list based on international collaborative work,” Drug Safety, vol. 33, no. 6, pp. 503–522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Suddek, “Protective role of thymoquinone against liver damage induced by tamoxifen in female rats,” Canadian Journal of Physiology and Pharmacology, vol. 92, no. 8, pp. 640–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. M. P. C. Ribeiro, A. E. Santos, and J. B. A. Custódio, “Mitochondria: the gateway for tamoxifen-induced liver injury,” Toxicology, vol. 323, pp. 10–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. C. Brase, D. Wuttig, R. Kuner, and H. Sültmann, “Serum microRNAs as non-invasive biomarkers for cancer,” Molecular Cancer, vol. 9, article 306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Albulescu, M. Neagu, L. Albulescu, and C. Tanase, “Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers,” Expert Review of Molecular Diagnostics, vol. 11, no. 1, pp. 101–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Ladeiro, G. Couchy, C. Balabaud et al., “MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations,” Hepatology, vol. 47, no. 6, pp. 1955–1963, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. O. F. Laterza, L. Lim, P. W. Garrett-Engele et al., “Plasma microRNAs as sensitive and specific biomarkers of tissue injury,” Clinical Chemistry, vol. 55, no. 11, pp. 1977–1983, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Laudadio, I. Manfroid, Y. Achouri et al., “A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation,” Gastroenterology, vol. 142, no. 1, pp. 119–129, 2012. View at Publisher · View at Google Scholar · View at Scopus